- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma in Poland
Total 407 results
-
CTI BioPharmaCompletedDiffuse Large B-cell Lymphoma | de Novo DLBCL | DLBCL Transformed From Indolent Lymphoma | Follicular Grade 3 LymphomaUnited States, Germany, Italy, United Kingdom, Hungary, France, Spain, Ukraine, Czechia, Austria, Belgium, Bulgaria, Denmark, Poland, Romania, Russian Federation, Slovakia
-
Gilead SciencesCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Small Lymphocytic LymphomaUnited States, United Kingdom, Italy, Germany, Poland, France
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Lymphoplasmacytic Lymphoma | Richter Syndrome | Indolent Non-Hodgkin LymphomaUnited States
-
Seagen Inc.TerminatedFollicular B-cell Non-Hodgkin's Lymphoma | Diffuse Large B-cell Lymphoma RefractoryUnited States, Italy, Spain, United Kingdom, Czechia, Poland, France
-
TG Therapeutics, Inc.TerminatedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic LymphomaUnited States, Poland, Australia, Italy, United Kingdom, Israel, Korea, Republic of, Slovakia, Spain
-
CelgeneTerminatedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaUnited States, Spain, United Kingdom, Germany, France, Czechia, Israel, Italy, Poland, Portugal, Puerto Rico, Russian Federation
-
National Cancer Institute (NCI)RecruitingLymphoplasmacytic Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Grade 3b Follicular... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Merkel Cell Carcinoma | Metastatic Merkel Cell Carcinoma | Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 | Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 | Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8 | Pathologic Stage IIIA Cutaneous Merkel... and other conditionsUnited States
-
University Medical Center GroningenHoffmann-La Roche; Amsterdam UMC, location VUmc; Stichting Hemato-Oncologie voor...WithdrawnDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedNetherlands
-
BayerActive, not recruitingLymphoma,Non-HodgkinChina, Hong Kong, Spain, Taiwan, Turkey, Japan, Russian Federation, Singapore, France, Austria, Bulgaria, Korea, Republic of, Malaysia, Thailand, United States, Hungary, Italy, Poland, Portugal, Germany, Mexico, Romania, Australia, Uk... and more
-
National Cancer Institute (NCI)CompletedMelanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Ocular Melanoma | Stage IIIC Cutaneous Melanoma AJCC v7 | Melanoma of Unknown Primary | Cutaneous Melanoma | Mucosal Melanoma | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7 | Stage... and other conditionsUnited States
-
Hoffmann-La RocheTerminatedNon-Hodgkin's LymphomaUnited States, Australia, Korea, Republic of, Germany, New Zealand
-
Novartis PharmaceuticalsActive, not recruitingNon-Hodgkin LymphomaSpain, Taiwan, Australia, Belgium, Germany, Italy, Singapore, Austria, France, Switzerland, Hong Kong, United States, Netherlands, Norway, United Kingdom, Brazil, China, Japan
-
The Netherlands Cancer InstituteDutch Cancer SocietyCompletedHodgkin Lymphoma | Diffuse Large B Cell LymphomaNetherlands
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Cutaneous Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Recurrent Cutaneous Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Recurrent Mucosal Melanoma | Metastatic Mucosal Melanoma | Non-Cutaneous Melanoma | Metastatic Non-Cutaneous Melanoma | Recurrent Non-Cutaneous...United States, Canada, Ireland
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaUnited States, Australia, Brazil, Canada, Mexico, New Zealand, Peru
-
Hoffmann-La RocheRecruitingNon-Hodgkin LymphomaUnited States, Korea, Republic of, China, Mexico, Japan, Brazil, Argentina, Thailand, Canada, Peru, Turkey, Russian Federation, Israel, New Zealand
-
Gilead SciencesTerminatedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma | Indolent Non-Hodgkin's LymphomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage I Childhood Hodgkin Lymphoma | Ann Arbor Stage II Childhood Hodgkin Lymphoma | Childhood Nodular Lymphocyte Predominant B-Cell LymphomaUnited States, Canada, Australia, New Zealand, Puerto Rico, Israel
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingLymphoma | Diffuse Large B-Cell Lymphoma | Hodgkin Lymphoma | Burkitt Lymphoma | Anaplastic Large Cell LymphomaUnited States, Canada
-
Gilead SciencesWithdrawnDiffuse Large B-Cell Lymphoma | Mediastinal B-cell LymphomaItaly, Spain, France, Poland
-
Molecular Templates, Inc.TerminatedLeukemia, Lymphocytic, Chronic, B-Cell | Diffuse Large B Cell Lymphoma | Blood Cancer | Hematological Malignancy | Small Lymphocytic Leukemia | Non-Hodgkin's B-cell LymphomaUnited States, Canada, Georgia, Belarus, Spain, Israel, Moldova, Republic of, Poland, Serbia, Ukraine
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Adult Acute Lymphoblastic Leukemia | Recurrent Adult Non-Hodgkin Lymphoma | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Non-Hodgkin LymphomaUnited States, Canada, Puerto Rico, Australia, Switzerland
-
Pharmacyclics LLC.Janssen PharmaceuticalsCompletedMantle Cell LymphomaUnited States, United Kingdom, Germany, Poland
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma | Refractory Neuroblastoma | Refractory Non-Hodgkin Lymphoma | Refractory Primary Central Nervous System Neoplasm | Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma and other conditionsUnited States, Puerto Rico
-
Polish Lymphoma Research GroupCompletedDiffuse Large B Cell LymphomaPoland
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityNot yet recruitingMantle Cell LymphomaUnited States
-
European Mantle Cell Lymphoma NetworkLymphoma Study Association; German Low Grade Lymphoma Study GroupUnknown
-
National Cancer Institute (NCI)Active, not recruitingDiffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Double-Expressor Lymphoma | EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma, Not Otherwise... and other conditionsUnited States
-
Athenex, Inc.RecruitingB-cell Lymphoma | CLL/SLL | ALL, Childhood | DLBCL - Diffuse Large B Cell Lymphoma | B-cell Leukemia | NHL, Relapsed, Adult | ALL, Adult B CellUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Incyte Corporation; Ipsen; BeiGeneRecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma | Grade 3b Follicular Lymphoma | Transformed Non-Hodgkin Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 RearrangementsUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingLocally Advanced Melanoma | Unresectable Melanoma | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Pathologic Stage IV Cutaneous Melanoma AJCC v8United States
-
Janssen Research & Development, LLCPharmacyclics LLC.TerminatedLymphoma, Non-HodgkinUnited States, France, Poland, United Kingdom, Germany, Taiwan, Spain, Bulgaria, Romania, Turkey, Ukraine, Canada, Korea, Republic of, Netherlands, Russian Federation, Belgium, Brazil, Hungary, Czechia, Sweden
-
Indapta Therapeutics, INC.RecruitingMultiple Myeloma | Refractory Multiple Myeloma | Refractory Non-Hodgkin Lymphoma | NHL | Blood Cancer | Relapsed Multiple Myeloma | Relapsed Non-Hodgkin LymphomaUnited States
-
Oregon Health and Science UniversityCompletedAcute Lymphoblastic Leukemia | Childhood Lymphoblastic LymphomaUnited States
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityCompletedRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityNot yet recruitingDiffuse Large B-Cell Lymphoma | High Grade B-Cell LymphomaUnited States
-
Juno Therapeutics, a Subsidiary of CelgeneBristol-Myers SquibbCompletedNeoplasms | Neoplasms by Histologic Type | Lymphoma | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoproliferative Disorders | Lymphatic Diseases | Immunoproliferative Disorders | Lymphoma, Non-Hodgkin | Immune System DisorderUnited States
-
CRISPR Therapeutics AGActive, not recruitingB-cell Lymphoma | Non-Hodgkin Lymphoma | B-cell Malignancy | Adult B Cell ALLUnited States, Spain, Canada, France, Germany, Australia
-
Brown UniversityWithdrawnDiffuse Large B Cell LymphomaUnited States
-
National Cancer Institute (NCI)Children's Oncology GroupActive, not recruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Rhabdoid Tumor | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Ann Arbor Stage III Hodgkin Lymphoma | Ann Arbor Stage IV Hodgkin Lymphoma | Recurrent Ependymoma | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent... and other conditionsUnited States, Puerto Rico
-
PfizerTerminatedMelanoma | Soft Tissue Sarcoma | Mycosis Fungoides | Breast Carcinoma | Solid Tumors | Squamous Cell Carcinoma | Human Papillomavirus-Related Malignant Neoplasm | Merkel-cell CarcinomaUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingUnresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Melanoma of Unknown Primary | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC... and other conditionsUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisChildren's Oncology GroupActive, not recruitingPrimary Mediastinal Large B Cell LymphomaFrance, Belgium, United Kingdom, Netherlands, Canada, Hungary, Italy, Poland, Spain
-
National Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Acute Myeloid Leukemia | Multiple Myeloma | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer... and other conditionsUnited States, Puerto Rico
-
MEI Pharma, Inc.TerminatedMarginal Zone Lymphoma | Non Hodgkin Lymphoma | Follicular Lymphoma (FL)United States, Spain, Korea, Republic of, Belgium, Taiwan, Germany, France, Italy, Australia, Poland, New Zealand, United Kingdom, Austria, Switzerland
-
Celldex TherapeuticsCompletedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma | Marginal Zone B Cell Lymphoma) | Any T-cell Malignancy | Solid Tumors (Metastatic Melanoma, Renal (Clear) Cell Carcinoma | Hormone-refractory Prostate Adenocarcinoma, Ovarian... and other conditionsUnited States
-
TG Therapeutics, Inc.CompletedMantle Cell Lymphoma | Chronic Lymphocytic LeukemiaUnited States
-
Polish Lymphoma Research GroupCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Small Lymphocytic LymphomaPoland
-
Hoffmann-La RocheActive, not recruitingDiffuse Large B-cell LymphomaUnited States, Israel, Spain, Korea, Republic of, Poland, Taiwan